International Clinical Trial: Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07471776) titled 'Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer' on March 10.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).

Primary Sponsor: Fudan University

Condition: Metastatic Breast Cancer ( HER2 Negative)

Intervention: Drug: Sacituzumab Govitecan?Datopotamab deruxtecan?Sacituzumab tirumotecan Diagnostic Test: 68Ga-TROP2 PET/CT Imaging

Recruitment Status: Recruiting

Phase: Phase 2

Date of First Enrollment: March 11, 2026

Target Samp...